J Long Term Eff Med Implants. 2006;16(6):451-7.
Ayaki M, Nishihara H, Yaguchi S, Koide R.
Department of Ophthalmology, Fujigaoka Hospital, Showa University School of Medicine, Japan. This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
PURPOSE: To investigate the light scattering properties of acrylic intraocular lenses (IOLs) placed in eyes treated with diclofenac sodium (Diclod, Wakamoto, Japan) and betamethasone phosphate (Rinderon, Shionogi, Japan) ophthalmic solutions.
METHODS:The light scattering properties of IOLs (MA30BA, Alcon laboratories) placed in 32 eyes treated with Diclod and 31 treated with Rinderon were evaluated 3 years after implantation using Scheimpflug photography.
RESULTS: The averaged intensity of glistenings was 9.0 CCT (computer compatible tapes) in the Diclod test group and 4.2 CCT in the Rinderon test group (p = 0.002). The intensity of surface light scattering for the Diclod and Rinderon test groups was 24.0 CCT and 26.9 CCT, respectively (p = 0.081).
CONCLUSION: The Diclod test group had a greater number of glistenings than the Rinderon test group. Both drugs have similar anti-inflammatory properties and Diclod, unlike Rinderon, also contains the surfactant polysorbate. We proposed that the presence of surfactant, or other ingredient, in commercially available eyedrops may enhance the development of glistenings.
PMID: 17956212 [PubMed - indexed for MEDLINE]